Pathogenetic features of anemia of chronic diseases in patients with malignant neoplasms and rheumatic pathology

Pathogenetic features of anemia of chronic diseases in patients with malignant neoplasms and rheumatic pathology

Objective: to study the importance of cytokines, hepcidin, a soluble transferrin receptor, iron metabolism in the development of anemia of chronic diseases in patients with malignant neoplasms and rheumatic pathology, to identify the leading factors in the development of anemia for each of the studi...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. T. Sakhin, M. A. Grigoriev, E. V. Kryukov, S. P. Kazakov, A. V. Sotnikov, A. V. Gordienko, O. A. Rukavitsyn
Format:	Article
Language:	Russian
Published:	ABV-press 2020-12-01
Series:	Онкогематология
Subjects:	anemia iron metabolism interleukin-6 interleukin-10 tumor necrosis factor α hepcidin soluble transferrin receptor
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/447
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of cytokine secretion and study of their effect on erythropoiesis in patients with malignant neoplasms with anemia of chronic disease, iron deficiency anemia, and their combination
by: V. T. Sakhin, et al.
Published: (2023-05-01)

ANEMIA OF CHRONIC DISEASE: FEATURES OF PATHOGENESIS AND POSSIBLE THERAPEUTIC CORRECTION (LITERATURE REVIEW AND RESULTS OF OWN RESEARCH)
by: V. Т. Sakhin, et al.
Published: (2018-05-01)

The role of hepcidin in the pathogenetic mechanisms of anemia of inflammation development in young children with acute inflammatory bacterial diseases of the respiratory system
by: H. O. Lezhenko, et al.
Published: (2020-08-01)

Differential diagnosis of anemia in pregnant women
by: T. S. Prokhorenko, et al.
Published: (2017-04-01)

The effect of eight-week yoga training on serum levels of interleukin 6, interleukin 10, tumor necrosis factor alpha and body composition in women with multiple sclerosis
by: Elham Maddah, et al.
Published: (2024-08-01)

THE ROLE OF TUMOR NECROSIS FACTOR-α G–308A, INTERLEUKIN-1β C–511T AND INTERLEUKIN-10 G–1082A GENE POLYMORPHISMS IN THE DEVELOPMENT OF SLOWLYRESOLVED COURSE OF COMMUNITY-ACQUIRED PNEUMONIA
by: V. I. Sovalkin, et al.
Published: (2013-12-01)

The use of hepcidin as a marker for diagnosing the type of anemia in patients with high activity of rheumatoid arthritis
by: A. S. Semashko, et al.
Published: (2023-12-01)

Diagnostic markers in the aspect of the development of HIV-encephalopathy in children
by: S. N. Saidkhodjaeva, et al.
Published: (2021-10-01)

Pathogenesis of anemia in pregnant women with gestational diabetes mellitus
by: A. P. Zima, et al.
Published: (2020-07-01)

The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma
by: Cheng-Der Liu, et al.
Published: (2021-01-01)

Pathogenetic and substitution correction of anemia in patients with malignant neoplasms
by: N. A. Romanenko, et al.
Published: (2020-10-01)

Levels of different cytokines in women and men with asymptomatic genital infection caused by Chlamydia
by: Alessandra Bua, et al.
Published: (2019-09-01)

FEATURES OF CEREBRAL HEMODYNAMICS AND MANIFESTATIONS OF HEPATIC ENCEPHALOPATHY IN CIRRHOSIS OF VIRAL ETIOLOGY AT DIFFERENT COMPENSATION STAGES WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION
by: V. E. Kulikov, et al.
Published: (2017-09-01)

POSSIBLE CHANGES IN THE CENTRAL HEMODYNAMICS IN PORTAL HYPERTENSION DUE TO LIVER CIRRHOSIS OF VIRAL ETIOLOGY WITH DIFFERENT LEVELS OF CYTOKINES
by: V. E Kulikov, et al.
Published: (2017-01-01)

Hepcidin as a Regulator of Iron Metabolism and Mediator of Inflammation in Patients with Chronic Heart Failure and Anemia of Chronic Diseases of the Elderly and Senile Age
by: N. I. Solomakhina, et al.
Published: (2022-11-01)

Case Report: Dual immunomodulatory and hematologic benefits of rituximab in refractory anemia of ANCA-associated vasculitis
by: Ningjun Shao, et al.
Published: (2025-08-01)

Potential biochemical markers of chronic bronchitis
by: E. A. Kurtukov, et al.
Published: (2021-07-01)

Inhibition of head and neck squamous cell carcinoma by Bruton’s tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cells
by: Anna R. Bopp, et al.
Published: (2025-05-01)

The role of interleukin-10 and its encoding gene polymorphism influence on the course of infections caused by varicella-zoster virus
by: N. V. Onishchenko, et al.
Published: (2020-02-01)

“CYTOKINE” MODEL OF PATHOGENESIS OF CHRONIC HEART FAILURE AND THE OPPORTUNITIES OF NEW THERAPEUTIC STRATEGY IN DECOMPENSATED PATIENTS
by: U. A. Vasuk, et al.
Published: (2016-01-01)

The effect of glucocorticoids combined with ulinastatin on IL⁃6/IL⁃10 balance and oxygenation index in patients with early acute lung injury after trauma
by: LI Tang，WANG Yudong，LI Wenchao
Published: (2025-08-01)

Pathogenesis and therapy of anemia in patients with inflammatory bowel diseases
by: O. V. Rybina, et al.
Published: (2024-04-01)

How to treat a patient with psoriatic arthritis and chronic lymphocytic leukemia?
by: Jürgen Braun, et al.
Published: (2024-06-01)

New areas of the pharmacotherapy of rheumatic diseases are inhibition of interleukin-6 and interleukin-17
by: Evgeny Lvovich Nasonov
Published: (2013-10-01)

Proinflammatory interleukins 2, 6 and tumor necrosis factor alpha in patients with hypertension and diabetes mellitus depending on the presence of metabolic-associated liver steatosis
by: O.M. Radchenko, et al.
Published: (2024-05-01)

Indicators of cytokine markers in patients with cardiovascular diseases
by: D. Kh. Kushkhova, et al.
Published: (2024-06-01)

Evaluation of proinflammatory cytokines and brain natriuretic peptide in patients with rheumatic heart diseases and coronary heart disease complicated by chronic heart insufficiency
by: N A Shoslak, et al.
Published: (2005-04-01)

Elevated serum IL-10/IL-6 ratio as a novel biomarker for secondary central nervous system lymphoma and poor prognosis in DLBCL
by: Jingjing Wen, et al.
Published: (2025-08-01)

Interleukin-10: A double-edged sword in breast cancer
by: Chun-Ming Chang, et al.
Published: (2021-01-01)

Targeting of interleukin-10 receptor by a potential human interleukin-10 peptide efficiently blocks interleukin-10 pathway-dependent cell proliferation
by: Chun-Chun Chang, et al.
Published: (2020-01-01)

SIGNIFICANCE OF INFLAMMATION MARKERS DETERMINED IN PREGNANT WOMEN WITH ANEMIC SYNDROME AND OBESITY
by: Т. S. Prokhorenko, et al.
Published: (2018-11-01)

EXPRESSION DENSITY OF RECEPTORS TO IMMUNOREGULATORY MEDIATORS AS A MODULATING COMPONENT OF BIOLOGICAL EFFECTS OF MEDIATORS ON CELL. PART 1
by: S. V. Sennikov, et al.
Published: (2019-05-01)

Identification of Early Biomarkers of Mortality in COVID-19 Hospitalized Patients: A LASSO-Based Cox and Logistic Approach
by: Anna Maria Fratta Pasini, et al.
Published: (2025-02-01)

Serum Levels of IL-6 Type Cytokines and Soluble IL-6 Receptors in Active B-Cell Chronic Lymphocytic Leukemia and in Cladribine Induced Remission
by: T. Robak, et al.
Published: (1999-01-01)

Assessment of Pro Hepcidin and Related with Iron Profile on Hemodialysis Men Patients
by: Baghdad Science Journal
Published: (2016-03-01)

MARKERS OF INFLAMMATION IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND CARDIOVASCULAR PATHOLOGY
by: Nataliya Valer'evna Seredavkina, et al.
Published: (2010-10-01)

No difference in inflammatory mediator expression between mast cell-rich and mast cell-poor rosacea lesions in Korean patients: a comparative study
by: Jin Ju Lee, et al.
Published: (2025-01-01)

Correlação entre o polimorfismo (-1082) da interleucina-10 e o desenvolvimento de carcinomas de pele
by: Daniela Rigo, et al.
Published: (2017-07-01)

Comparative analysis of the concentrations of proinflammatory cytokines and glycosylated ferritin in patients with idiopathic recurrent pericarditis and adult-onset Still's disease
by: V. Yu. Myachikova, et al.
Published: (2021-12-01)

Anemia of chronic diseases: the important aspects of pathogenesis and treatment
by: O. A. Rukavitsyn
Published: (2016-03-01)